Clinical Trial

Defining Retinal and Choroidal Structures Using Hyperspectral Imaging

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
This study has been transferred to the Human Research Ethics Committee of St Vincent's Hospital Melbourne.
Summary
This study investigates a novel, non-invasive imaging technique called hyperspectral retinal imaging to improve the identification and characterisation of retinal and choroidal structures in both healthy and diseased eyes. Hyperspectral imaging captures retinal images across multiple wavelengths of light, generating detailed spectral information that may reveal biological and structural features not visible with conventional retinal photography. Approximately 1000 participants will undergo retinal imaging at specialist eye clinics in Melbourne, Australia. The study aims to determine whether hyperspectral imaging can detect spectral signatures associated with retinal and optic nerve diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration, and whether these signatures correlate with disease severity.
Trial Details
NCT Number NCT07530783
Lead Sponsor Center for Eye Research Australia
Conditions Retinal Disease
Enrollment 679 participants
Start Date 2016-02-25
Primary Completion 2025-01-21 (estimated)
Study Completion 2025-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-04-15